Vaccines, blood, antisera, toxins and cultures in   Germany

Exports In 2022, Germany exported $45.5B in Vaccines, blood, antisera, toxins and cultures, making it the 5th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most exported product in Germany. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Germany are: United States ($9.2B), Netherlands ($4.65B), Italy ($4.13B), Switzerland ($3.88B), and France ($2B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Germany between 2021 and 2022 were Netherlands ($3.19B), United States ($854M), and Australia ($383M).

Imports In 2022, Germany imported $36B in Vaccines, blood, antisera, toxins and cultures, becoming the 2nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Germany. Germany imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($7.86B), Switzerland ($6.49B), United States ($4.97B), Ireland ($4.59B), and Netherlands ($3.15B).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Germany between 2021 and 2022 were Ireland ($1.2B), United States ($528M), and Spain ($203M).

COMPANIES In 2023, leading companies such as were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Germany to the United States.